Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Crit Care Med. 2022 Feb 1;50(2):e143–e153. doi: 10.1097/CCM.0000000000005272

Table 3.

Quantitative Pupil Characteristics Prior to First-Time NOA (218 patients, 3625 total observations)

A. Size difference (mm) prior to pupil observations NOA (M=138) vs. No NOA (M=3487)

Diff Size OR [95% CI] p

One observation prior (N=191, M=3282) 10.34 [5.08, 20.80] <0.001*
Two observations prior (N=167 M=2898) 6.99 [3.09, 15.45] <0.001*
Three observations prior (N=146, M=2314) 6.04 [2.40, 14.77] <0.001*
Four observations prior (N=123, M=1773) 13.27 [4.65, 36.95] <0.001*

B. Minimum NPi prior to FT-NOA pupil observations NOA-Abnormal (M=44) vs. NOA-Normal (M=94)

Min NPi OR [95% CI] p

One observation prior (N=107, M=107) 0.25 [0.12, 0.45] <0.001*
Two observations prior (N=88, M=88) 0.26 [0.11, 0.47] <0.001*
Three observations prior (N=69, M=69) 0.21 [0.07, 0.44] <0.001*
Four observations prior (N=52, M=52) 0.24 [0.07, 0.53] 0.004*

Panel A reports univariate mixed effects logistic regression models to account for inter-subject variability testing first-time NOA and size difference up to four observations prior. Panel B reports univariate logistic regression for first-time NOA phenotype and minimum NPi. All models adjust for GCS and osmotic medications prior to observation. Abbreviations: OR = Odds Ratio, CI = Confidence Interval, NOA = New Onset Anisocoria, FT-NOA = First-Time NOA, N=patients, M=observations. Observational sample sizes are included in Supplementary Methods.